(From left) Doctoral student Hannah Yamagata, research assistant professor Kushol Gupta, and postdoctoral fellow Marshall Padilla holding 3D-printed models of nanoparticles.
(Image: Bella Ciervo)
PHILADELPHIA - By studying tumor biology at the molecular level, researchers are gaining a deeper understanding of drug resistance - and how to avoid it by designing pediatric cancer treatments tailored to specific mutations in a child’s DNA. In a fruitful collaboration, pediatric oncologists and biochemists are targeting neuroblastoma, an often-deadly childhood cancer of the peripheral nervous system.
"This has been a terrific collaboration," said study co-leader Mark A. Lemmon, Ph.D., professor and chair of Biochemistry and Biophysics at the Perelman School of Medicine of the University of Pennsylvania. "We have been working for a long time to understand how growth factor receptors work as signaling 'machines.'"
Click here to view the full release.
Karen Kreeger
(From left) Doctoral student Hannah Yamagata, research assistant professor Kushol Gupta, and postdoctoral fellow Marshall Padilla holding 3D-printed models of nanoparticles.
(Image: Bella Ciervo)
Jin Liu, Penn’s newest economics faculty member, specializes in international trade.
nocred
nocred
nocred